In vitro screening of traditionally used medicinal plants in China against enteroviruses

World Journal of Gastroenterology

Volumn 12, Issue 25, 2006, Pages 4078-4081

  Guo, Jin Peng ^a   Pang, Ji ^a   Wang, Xin Wei ^a   Shen, Zhi Qiang ^a   Jin, Min ^a   Li, Jun Wen ^a  

^a Institute of Environment and Health   (China)

Author keywords

Antiviral activity; China; Cyrtomium fortunei J. sm.; Enterovirus; Paeonia veitchii Lynch.; Sargentodoxa cuneata (Oliv) Reld. et. Wils.; Sophora tonkinensis Gapnep.; Spatholobus suberectus Dunn; Traditional used medicinal plant

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; ANTIVIRUS AGENT; ARCTIUM LAPPA EXTRACT; BELAN ANDA CHINENSIS EXTRACT; CHINESE DRUG; CYRTOMIUM FORTUNEI EXTRACT; DICTANNUS DASYCARPUS EXTRACT; EPHEDRA SINICA EXTRACT; EPIMEDIUM BREVICORNUM EXTRACT; HERBACEOUS AGENT; LINDERA AGGREGATA EXTRACT; LYGODIUM JAPONICUM EXTRACT; PAEONIA LACTIFLORA EXTRACT; PAEONIA VEITCHII EXTRACT; PATRINIA EXTRACT; PLANTAGO ASIATICA EXTRACT; SARGENTODOXA CUNEATA EXTRACT; SOPHORA TONKINENSIS EXTRACT; SPATHOLOBUS SUBERECTUS EXTRACT; TERMINALIA CHEBULA EXTRACT; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTIVIRAL ACTIVITY; ARTICLE; CHINA; COLORIMETRY; CONTROLLED STUDY; COXSACKIE VIRUS; COXSACKIE VIRUS B3; CYTOTOXICITY; DRUG POTENCY; DRUG SCREENING; ECHO VIRUS; ENTEROVIRUS; IN VITRO STUDY; INHIBITION KINETICS; MEDICINAL PLANT; NONHUMAN; POLIOMYELITIS VIRUS 1; TRADITIONAL MEDICINE; VERO CELL; VIRUS ADSORPTION; VIRUS INACTIVATION; VIRUS REPLICATION;

EID: 33746238290     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v12.i25.4078     Document Type: Article

References (24)

1. Martino TA, Liu P, Petric M, Sole MJ. Enteroviral myocarditis and dilated cardiomyopathy: a rewiew of clinical and experimental studies. In: Rotbart, H.A. (Ed.), Human Enterovirus Infections. ASM Press, Washington DC, 1995: 291-351
2. Sole MJ, Liu P. Viral myocarditis: a paradigm for understanding the pathogenesis and treatment of dilated cardiomyopathy. J Am Coll Cardiol 1993; 22: 99A-105A
3. Fujioka S, Kitaura Y. Coxsackie B virus infection in idiopathic dilated cardiomyopathy: clinical and pharmacological implications. BioDrugs 2001; 15: 791-799
4. Dalakas MC. Enteroviruses and human neuromuscular diseases. In: Rotbart, H.A. (Ed.), Human Enterovirus Infections. ASM Press, Washington DC, 1995: 387-398
5. Rewers M, Atkinson M. The possible role of enteroviruses in diabetes mellitus. In: Rotbart, H.A. (Ed.), Human Enterovirus Infections. ASM Press, Washington DC, 1995: 291-351
6. Muir P, Nicholson F, Illavia SJ, McNeil TS, Ajetunmobi JF, Dunn H, Starkey WG, Reetoo KN, Cary NR, Parameshwar J, Banatvala JE. Serological and molecular evidence of enterovirus infection in patients with end-stage dilated cardiomyopathy. Heart 1996; 76: 243-249
7. Rotbart HA. Treatment of picornavirus infections. Antiviral Res 2002; 53: 83-98
8. Carrasco L. Picornavirus inhibitors. Pharmacol Ther 1994; 64: 215-290
9. Loddo B. Development of drug resistance and dependence in viruses. Pharmacol Ther 1980; 10: 431-460
10. Nikolaeva L, Galabov AS. In vitro inhibitory effects of dual combinations of picornavirus replication inhibitors. Acta Virol 1999; 43: 303-311
11. Vlietinck AJ, Vanden Berghe DA, Haemers A. Present status and prospects of flavonoids as anti-viral agents. Prog Clin Biol Res 1988; 280: 283-299
12. Tabba HD, Chang RS, Smith KM. Isolation, purification, and partial characterization of prunellin, an anti-HIV component from aqueous extracts of Prunella vulgaris. Antiviral Res 1989; 11: 263-273
13. Cowan MM. Plant products as antimicrobial agents. Clin Microbiol Rev 1999; 12: 564-582
14. Kurokawa M, Ochiai H, Nagasaka K, Neki M, Xu H, Kadota S, Sutardjo S, Matsumoto T, Namba T, Shiraki K. Antiviral traditional medicines against herpes simplex virus (HSV-1), poliovirus, and measles virus in vitro and their therapeutic efficacies for HSV-1 infection in mice. Antiviral Res 1993; 22: 175-188
15. Kaij-a-Kamb M, Amoros M, Girre L. Search for new antiviral agents of plant origin. Pharm Acta Helv 1992; 67: 130-147
16. Li ZH, Nie BM, Chen H, Chen SY, He P, Lu Y, Guo XK, Liu JX. In vitro anti-coxsackievirus B(3) effect of ethyl acetate extract of Tian-hua-fen. World J Gastroenterol 2004; 10: 2263-2266
17. Cavallaro U, Soria MR. Targeting plant toxins to the urokinase and alpha 2-macroglobulin receptors. Semin Cancer Biol 1995; 6: 269-278
18. Vlietinck AJ, Vanden Berghe DA. Can ethnopharmacology contribute to the development of antiviral drugs? J Ethnopharmacol 1991; 32: 141-153
19. Baker JT, Borris RP, Carte B, Cordell GA, Soejarto DD, Cragg GM, Gupta MP, Iwu MM, Madulid DR, Tyler VE. Natural product drug discovery and development: new perspectives on international collaboration. J Nat Prod 1995; 58: 1325-1357
20. Krah DL. A simplified multiwell plate assay for the measurement of hepatitis A virus infectivity. Biologicals 1991; 19: 223-227
21. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 1983; 65: 55-63
22. Chiang LC, Chiang W, Chang MY, Ng LT, Lin CC. Antiviral activity of Plantago major extracts and related compounds in vitro. Antiviral Res 2002; 55: 53-62
23. Chiang LC, Chiang W, Yu HS, Sheu HM, Chen HY. Establishment and characterization of a continuous human basal cell carcinoma cell line from facial skin (I) cytological behavior of early passages. Gaoxiong Yixue Kexue Zazhi 1994; 10: 170-176
24. Cragg GM, Newman DJ, Snader KM. Natural products in drug discovery and development. J Nat Prod 1997; 60: 52-60